Interaction between warfarin and molnupiravir in a patient with coronavirus disease 2019 infection

Molnupiravir is a novel antiviral agent for coronavirus disease 2019 (COVID-19) treatment. Warfarin is an oral anticoagulation agent with difficult management due to drug interactions. Here, we describe a case of international normalized ratio (INR) prolongation in a patient who administrated warfar...

Full description

Bibliographic Details
Main Authors: Hikari Mizutani, Tetsuro Koide, Takashi Omura, Kumiko Ito
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
Online Access:http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=11;spage=7463;epage=7465;aulast=Mizutani